Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
EBIT MarginEBITDA MarginEBT MarginNet MarginOperating MarginReturn on Sales

ProQR Therapeutics (PRQR) FCF Margin (2021 - 2025)

Historic FCF Margin for ProQR Therapeutics (PRQR) over the last 2 years, with Q4 2022 value amounting to 2675.28%.

  • ProQR Therapeutics' FCF Margin fell 43531000.0% to 2675.28% in Q4 2022 from the same period last year, while for Sep 2023 it was 463.37%, marking a year-over-year increase of 9956300.0%. This contributed to the annual value of 214.17% for FY2024, which is 5239200.0% down from last year.
  • Latest data reveals that ProQR Therapeutics reported FCF Margin of 2675.28% as of Q4 2022, which was down 43531000.0% from 1857.25% recorded in Q3 2022.
  • Over the past 5 years, ProQR Therapeutics' FCF Margin peaked at 1677.82% during Q4 2021, and registered a low of 8318.44% during Q1 2021.